Download this whitepaper.
While the concept of artificial intelligence (AI) began gelling more than 50 years ago, its use in the pharmaceutical industry is just starting to gain significant traction. In January, the first drug designed entirely using AI entered the human clinical trials phase—five times faster than it usually takes to get a drug to this stage. But is the rest of the industry ready to deploy AI technologies?
Offered Free by: OpenText
See All Resources from: OpenText